How drug companies are sidestepping the WHO's technology transfer hub in Africa
The decisions by BioNTech and Moderna to invest in other vaccine sites in African and not assist the mRNA Technology Transfer Hub in South Africa will prolong the social and economic costs of the pandemic, says David Richard Walwyn.